Robot shoes could help PAD patients walk better
NCT ID NCT04337554
First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 38 times
Summary
This study tested special exoskeleton footwear designed to assist walking in people over 40 with and without peripheral artery disease (PAD). Researchers measured how the shoes affected walking mechanics, muscle oxygen, and energy use, and asked participants about comfort and fatigue. The goal was to find the best level of assistance to improve walking performance.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE
Omaha, Nebraska, 68105-1850, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
exoskeleton footwear
What this could lead to
If successful, this device could help people with PAD walk more easily and with less discomfort.
What could go wrong
This was a small, early-stage study (47 participants) focused on finding the best assistance level, not proving long-term benefits. Results may not apply to everyone.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.